Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients

por Fröhlich, Anne, Niebel, Dennis, Fietz, Simon, Egger, Eva, Buchner, Andrea, Sirokay, Judith, Landsberg, Jennifer
Publicado 2020